Divergent Trends in Orange Book and Biologic Patent Litigation Revealed in Updated USPTO Report
The USPTO recently published an updated report on Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings, which spotlighted the Orange Book or biologic patents. These findings incorporate data until March 31, 2023, offering a revealing look into this crucial patent litigation realm. Significant for stakeholders navigating this intricate field are marked variances in…